New hearing, same blame game: Pharma, PBMs trade accusations ahead of Senate session

A day before the Senate’s Health, Education, Labor, and Pensions (HELP) Committee meets to discuss the high cost of prescription drugs in America, the pharma industry and pharmacy benefit managers are once again pointing fingers.

Sen. Bernie Sanders (I-VT) has called three pharma CEOs — Merck’s Robert Davis, Johnson &…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks